| Product Information |
|
| Registration Number |
DR-XY26134
|
| Generic Name |
Fludarabine Phosphate
|
| Brand Name |
Fludara
|
| Dosage Strength |
50mg
|
| Dosage Form |
Powder For Injection (IV)
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
Type I Clear glass vial (Box of 5's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Baxter Oncology GmbH
|
| Country of Origin |
switzerland
|
| Trader |
N/A
|
| Importer |
N/A
|
| Distributor |
N/A
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
26 October 2022
|
| Expiry Date |
05 May 2025
|